Sci Simple

New Science Research Articles Everyday

# Health Sciences # Genetic and Genomic Medicine

Chorangiomas: The Hidden Threats in Pregnancy

Learn about chorangiomas and their potential risks during pregnancy.

Brandon M. Wilk, Manavalan Gajapathy, Donna M. Brown, Virginia E. Duncan, Elizabeth A. Worthey

― 6 min read


Chorangiomas in Pregnancy Chorangiomas in Pregnancy tumors. Exploring risks and causes of placental
Table of Contents

Chorangiomas, also known as chorioangiomas, are non-cancerous tumors found in the placenta. They happen in about 1 out of every 100 pregnancies, usually appearing as single nodules. While these growths are typically harmless, larger or multiple chorangiomas can lead to various issues, both for the baby and the mother. It’s like finding a wayward sock in your laundry; most of the time, it’s just a minor annoyance, but sometimes it can lead to a bigger mess.

The Risks of Large or Multiple Chorangiomas

In rare cases where a chorangioma grows larger than 4 cm or if there are many of them, serious complications can arise. These include conditions like polyhydramnios (too much amniotic fluid), heart failure due to blood shunting, growth restriction in the baby, Hydrops Fetalis (a serious condition leading to excess fluid in the baby), preterm delivery, unexpected fetal death, and even stillbirth. Mothers may also face higher risks of preeclampsia and HELLP syndrome, both of which can be life-threatening.

A study looking into various cases of chorangiomas found that only 4 out of 11 babies survived when these tumors were present in a more severe form. It is important to keep in mind that chorangiomas are often discovered in the second trimester or later, but they can sometimes be found accidentally during other medical issues or even after birth.

What Causes Chorangiomas?

The exact reasons why chorangiomas form are still unclear. They have been observed alongside other growths, like placental mesenchymal dysplasia, in a genetic condition known as Beckwith-Wiedemann syndrome. However, the link between the two conditions is still up for debate. Some cases suggest there might be a genetic tendency, especially seen in families with multiple chorangiomas across different pregnancies. Despite these observations, instances of genetic predisposition remain rare.

Research has connected chorangiomas to environmental factors too. For example, they tend to occur more often in native high-altitude populations where oxygen levels are lower, or hypobaric hypoxia is present. They are also more frequently seen in poorly perfused areas of the placenta. A substance called vascular endothelial growth factor (VEGF) appears to play a role, as it is often involved in the formation of new blood vessels in response to low oxygen levels.

Studies have also indicated that chorangiomas are more common in pregnancies involving multiples, like twins or triplets. However, the reasons behind this association aren’t entirely known yet.

A Unique Case of Twin Chorangiomas

In a compelling case involving identical twins sharing a placenta, one twin had multiple chorangiomas, while the other did not. This unusual situation offered a great opportunity to investigate the factors contributing to the difference in placental health. To find out why only one twin's placenta was affected, researchers took various tissue samples for deeper analysis.

The chorangiomas were all located in the area of the placenta belonging to the first twin, leading to an imbalance in placental territory sizes. Birth weights for these twins were lower than expected, but both babies were delivered safely via C-section. The twins had healthy Apgar scores, which is a quick assessment done right after birth.

The Search for Underlying Factors

After carefully examining each sample, scientists looked for genetic differences and changes that could explain why one twin's placenta experienced these issues. They used advanced methods to analyze the DNA and RNA from the chorangiomas and surrounding placental tissues. This allowed them to identify specific variations that could influence chorangioma development.

One significant finding was a variant in a gene known as EPAS1, which helps respond to low oxygen levels. This gene was present in the chorangioma tissue and suggested the growth may be linked to early development stages. Essentially, it indicated the placenta may not have adapted well to lower oxygen levels, leading to growth issues.

Genetic and Environmental Interplay

Researchers believe that both genetic and environmental factors contributed to the chorangioma development in this case. The twins shared a placenta, which meant they had to compete for resources. This shared environment may have increased the stress on the placenta, leading to the formation of chorangiomas in only one of the twins.

In addition to the genetic findings, other changes in gene expression were observed in the chorangioma tissue. One particular gene, Leptin, related to regulating body weight and energy balance, showed increased activity in the chorangiomas. This protein is also involved in processes like angiogenesis, which is the formation of new blood vessels. So, when the body tries to fix the vasculature problem, it might instead increase the issue.

The Role of Reactive Oxygen Species

The researchers discovered that many of the mutations present in the chorangioma tissue were linked to reactive oxygen species (ROS), which are unstable molecules that can cause damage to DNA. These molecules can accumulate due to factors like rapid cell division, high energy use, or abnormal blood vessel structures.

In this case, the host of mutations and expressions in the chorangiomas indicated that the tissue was under stress – much like when you try to do too many things at once and your brain starts to short-circuit. The abnormal blood supply in the chorangiomas may have led to frequent cycles of low oxygen and high oxygen conditions, resulting in a further build-up of ROS.

Implications for Future Research

The findings from this case highlight the complexity of chorangioma development. While individualized genetic variations were linked to the growth, environmental stressors cannot be overlooked. The interplay of genetic and environmental factors can create a situation where the placenta struggles to adapt, leading to complications.

As chorangiomas are typically benign, understanding their development better could provide insights into treatments and management strategies. More studies focusing on genetic and environmental influences could help paint a clearer picture.

Given that chorangiomas are uncommon, it might be challenging to gather sufficient data from multiple cases. However, researchers suggest that studying similar conditions in animal models, like guinea pigs or baboons, could improve understanding. These animal models share some physiological features with humans and could reveal more about how hypoxia and gene changes affect placental health.

The Final Takeaway

Although chirangiomas might sound worrisome, it’s essential to remember that they are largely non-cancerous and often don’t cause any harm. This rare case showcases how one twin can face challenges while the other remains unaffected. The complexity of their development underscores the delicate balance of genetics, environment, and individual health.

So, the next time you hear about a chorangioma, remember: they may be a little pesky, like socks that always seem to go missing in the laundry, but there’s a whole lot more going on under the surface! As researchers continue to study these fascinating growths, we can hope they unravel more of the mysteries surrounding this unique aspect of placental health.

Original Source

Title: Multi-omic analysis identifies a multi-step pathology in a case of multiple chorangioma syndrome in monochorionic twins.

Abstract: BackgroundChorangiomas, benign proliferative capillary lesions in the placenta, occur in approximately 1% of births, typically as a solitary nodule. In rare cases, multiple nodules develop, posing risks of fetal heart failure, hydrops fetalis, and intrauterine death due to altered placental hemodynamics. Although genetic and hypoxic factors have been hypothesized to drive aberrant angiogenesis, definitive evidence has been lacking. We report on a unique case of multiple chorangiomas in half of a shared placenta in monozygotic, monochorionic diamniotic (MCDA) twins, providing an unprecedented opportunity to explore impacts that molecular variation has on chorangioma formation. ResultsWhole genome and bulk RNA sequencing supported identification of early embryonic or germline and somatic variation. It revealed a likely pathogenic heterozygous frameshift deletion in EPAS1, a hypoxia-sensing transcription factor, with an early embryonic or germline origin. This variant likely impaired placental oxygen regulation and angiogenesis through its impact on VEGF-related pathways. Deleterious somatic mutations in COL1A1, FBXO11, and TRIM71 were observed within the chorangioma-affected tissue, along with increased expression of Leptin and DNA damage signatures consistent with oxidative stress. In contrast, the unaffected twins placental territory showed a different pattern of pathogenic somatic variation with the presence of a known pathogenic variant in MUTYH and signs of repair deficiencies. These findings highlight the presence of predisposing events and distinct molecular processes within each domain of the shared placenta. We propose that these molecular events, combined with environmental factors intensified by the MCDA pregnancy, likely contributed to chorangioma development.. ConclusionsOur study provides novel insights into the molecular basis of multiple chorangioma syndrome. To our knowledge, this is the first molecular evidence implicating both germline and somatic genetic involvement in this condition. The identification of molecular signatures previously associated with malignancy suggests that chorangiomas may share pathways with oncogenic processes. These findings highlight the importance of considering both genetic and environmental interactions in placental pathologies, offering potential implications for understanding and managing complex vascular and placental conditions, including preeclampsia, intrauterine growth restriction, and fetal vascular malperfusion.

Authors: Brandon M. Wilk, Manavalan Gajapathy, Donna M. Brown, Virginia E. Duncan, Elizabeth A. Worthey

Last Update: 2024-12-05 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.12.03.24318397

Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.03.24318397.full.pdf

Licence: https://creativecommons.org/licenses/by-nc/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

Similar Articles